ID

16730

Description

Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc (OSI Pharmaceuticals) A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of single-agent Tarceva® (erlotinib) following complete tumor resection with or without adjuvant chemotherapy in patients with stage IB-IIIA non-small cell lung carcinoma who have EGFR-positive tumors. See https://clinicaltrials.gov/ct2/show/NCT00373425 Part of study: Concomitant Medications

Link

https://clinicaltrials.gov/ct2/show/NCT00373425

Keywords

Versions (2)
  1. 8/2/16 8/2/16 -
  2. 8/3/16 8/3/16 - Julian Varghese
Uploaded on

August 3, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Concomitant Medications, Tarceva in NSCLC patients who have EGFR-positive tumors DRKS00001485 NCT00373425

English

Concomitant Medications, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

1 forms  
Concomitant Medications
Description

Concomitant Medications

Concomitant Medication
Description

Concomitant Medication

Data type

boolean

Alias
UMLS CUI [1]
C2347852
Medications
Description

Medications

Medication (Use generic name when possible)
Description

Concomitant Medication

Data type

text

Alias
UMLS CUI [1]
C2347852
Prophylaxis
Description

Indication Prophylaxis

Data type

boolean

Alias
UMLS CUI [1,1]
C2826696
UMLS CUI [1,2]
C0199176
Indication
Description

Indication

Data type

text

Alias
UMLS CUI [1]
C2826696
Date started: Prestudy
Description

Concomitant Medication Start Date

Data type

boolean

Alias
UMLS CUI [1]
C2826734
Date started
Description

Concomitant Medication Start Date

Data type

date

Alias
UMLS CUI [1]
C2826734
Date stopped: Post treatment
Description

Concomitant Medication End Date

Data type

boolean

Alias
UMLS CUI [1]
C2826744
Date stopped
Description

Concomitant Medication End Date

Data type

date

Alias
UMLS CUI [1]
C2826744
Back to the top of the page

Similar models

Concomitant Medications, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Concomitant Medications
Concomitant Medication
Item
Concomitant Medication
boolean
C2347852 (UMLS CUI [1])
Item Group
Medications
Concomitant Medication
Item
Medication (Use generic name when possible)
text
C2347852 (UMLS CUI [1])
Indication Prophylaxis
Item
Prophylaxis
boolean
C2826696 (UMLS CUI [1,1])
C0199176 (UMLS CUI [1,2])
Indication
Item
Indication
text
C2826696 (UMLS CUI [1])
Concomitant Medication Start Date
Item
Date started: Prestudy
boolean
C2826734 (UMLS CUI [1])
Concomitant Medication Start Date
Item
Date started
date
C2826734 (UMLS CUI [1])
Concomitant Medication End Date
Item
Date stopped: Post treatment
boolean
C2826744 (UMLS CUI [1])
Concomitant Medication End Date
Item
Date stopped
date
C2826744 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial